• Startup Antidote raises £11m biospectrumasia
    September 18, 2017
    Antidote Technologies, a clinical trial matching platform, has raised £11m in a funding round led by Merck Global Health Innovation Fund (GHI) and joined by existing investors Smedvig Capital and Octopus Ventures.
PharmaSources Customer Service